Renal Denervation: The Latest Data and Implications for Clinical Practice
The overall goal of this education is to provide participants with an update on the latest science on contemporary approaches to hypertension management.
In this webinar, you will hear about the burden of hypertension in the Veteran Affairs (VA) community, renal denervation (RDN) and clinical trials, as well as see an example of VA hypertension and clinical considerations learned from the RDN clinical trial experience.
Key Objectives/Learning Outcomes:
- Explore the latest trials and science in support of RDN as an innovative approach for hypertension management
- Understand how RDN may impact the approach to hypertension management and overall patient care, specifically as it pertains to cardiac professionals working in the federal system.
Educational grant support provided by Medtronic. Click here to learn more.
Michael Fischer, MD
Chandan Devireddy, MD, FACC
Vasilios Papademetriou, MD
Joint Accreditation Statement
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The ACCF designates this blended/other (live and on-demand) activity for a maximum of up to 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ACCF designates this educational activity for a maximum of 1 continuing nursing education contact hours.
To claim credit for participating in this webinar, contact email@example.com.
Clinical Topics: Prevention